Telavancin Hydrochloride

elavancin hydrochloride (TD-6424 hydrochloride) is a bactericidal agent that exhibits inhibitory activity against Staphylococcus aureus. Telavancin hydrochloride inhibits bacterial cell wall synthesis by binding to the lipid-linked N-acetylglucosamine-N-muramyl pentapeptide (with a D-Ala-D-Ala terminus), a peptidoglycan precursor, and blocks the transglycosylation and transpeptidation steps. Telavancin hydrochloride disrupts bacterial membrane barrier function, induces dissipation of bacterial membrane potential, and causes leakage of cytoplasmic ATP and potassium ions, with its activity restricted exclusively to bacterial membranes. Telavancin hydrochloride can be used in research on bacterial infections, central venous catheter-related bloodstream infections, and Gram-positive bacterial pneumonia.


Cat. No.: EX-A7014	Purity: >98%

	Chemical structure of Telavancin Hydrochloride

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
10mg	300	In-stock
25mg	432	In-stock
100mg	716	In-stock
1g	get quote	In-stock
5g	get quote	In-stock
10g	get quote	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	TD 6424
CAS No.	560130-42-9
Purity	>98%
Formula	C80H107Cl3N11O27P
Mol Weight	1792.096
Color	White to off-white
State	solid powder
Solubility	Soluble in DMSO 25 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder 4°C, sealed storage, away from moisture; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Lyseng-Williamson KA, et al. Telavancin. Drugs. 2009;69(18):2607-20. [2]. Bookstaver PB, et al. Stability and compatibility of antimicrobial lock solutions. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2013 Dec 15;70(24):2185-98. [3]. Saravolatz LD, et al. Telavancin: a novel lipoglycopeptide. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Dec 15;49(12):1908-14.
CoA	CoA of Telavancin Hydrochloride


		Search